SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-022036
Filing Date
2024-02-28
Accepted
2024-02-28 16:01:45
Documents
125
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K srpt-20231231.htm   iXBRL 10-K 5018466
2 EX-10.71 srpt-ex10_71.htm EX-10.71 41036
3 EX-10.72 srpt-ex10_72.htm EX-10.72 42956
4 EX-10.73 srpt-ex10_73.htm EX-10.73 41733
5 EX-10.74 srpt-ex10_74.htm EX-10.74 38521
6 EX-10.77 srpt-ex10_77.htm EX-10.77 45865
7 EX-21.1 srpt-ex21_1.htm EX-21.1 5232
8 EX-23.1 srpt-ex23_1.htm EX-23.1 3591
9 EX-31.1 srpt-ex31_1.htm EX-31.1 10225
10 EX-31.2 srpt-ex31_2.htm EX-31.2 10346
11 EX-32.1 srpt-ex32_1.htm EX-32.1 8224
12 EX-32.2 srpt-ex32_2.htm EX-32.2 8211
13 GRAPHIC img78802856_0.jpg GRAPHIC 59693
14 GRAPHIC img78802856_1.jpg GRAPHIC 56185
  Complete submission text file 0000950170-24-022036.txt   19223364

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT srpt-20231231.xsd EX-101.SCH 2380213
127 EXTRACTED XBRL INSTANCE DOCUMENT srpt-20231231_htm.xml XML 3591766
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14895 | Film No.: 24695048
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)